12:00 AM
 | 
Sep 10, 2012
 |  BC Week In Review  |  Company News  |  Deals

BioLineRx, Biokine deal

Biokine granted BioLineRx exclusive, worldwide rights to develop and commercialize BL-8040 (formerly BKT-140). BioLineRx expects to begin a Phase II trial of the CXC...

Read the full 127 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >